Imoto S, Yamauchi C, Komoike Y, Tsugawa K, Yotsumoto D, Wada N, Ueno T, Oba M S., ShienT, Sugae S, Tsuda H, Yoneyama K
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by aquetionnaire from the Japanese Breast Cancer Society.
Breast Cancer , 2016;24：427-432.
Shimo A, Tsugawa K, Tsuchiya S, Yoshie R, Tsuchiya K, Uejima T, Kojima Y, Shimo A, Hayami R, Nishikawa T, Yabuki Y, Kawamoto H, Sudo A, Fukuda M, Kanemaki Y, Maeda I
Oncologic outcomes and technical considerations of nipple-sparing mastectomies in breast cancer:experience of 425 cases from a single institution.
Breast Cancer , 2016;23(6)：851-860.
Maeda I, Abe K, Koizumi H, Nakajima C, Tajima S, Aoki H, Tsuchiya J, Tsuchiya S, Tsuchiya K, Shimo A, Tsugawa K, Ueno T, Tatsunami S, Takagi M
Comparison between Ki67 labeling index determined using image analysis software with virtual slide
system and that determined visually in breast cancer.
Breast Cancer , 2016;23(5)：745-751.
Oi R, Koizumi H, Maeda I, Noguchi A, Tatsunami S, Iwatani T, Kawamoto H, Tsugawa K, Takagi M
Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer.
Breast Cancer , 2016;10：211-221.
Zembutsu H, Nakamura S, Akashi-T S, Kuyama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H , Hasegawa Y , Kutomi G , Shima H, Fukino S, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Ern YT, Mikael H, Ching-WC, Soo CL, Nakamura Y
Significant effect of polymorphisms in CYP2D6 on response to Tamoxifen Therapy for Breast Cancer : A prospective multicenter study.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2016;23：2019-2026.
Kojima-T S, Ohta Y, Takenaga M, Niimi J, Watanabe D, Tsunoda S, Ootaki M, Oishi S, Fujii N, Matsumoto N, Tsugawa K
A novel KSP Inhibitor, KPYB10602, induces mitotic arrest and cell death in breast cancer cells.
Journal of St.Marianna University , 2016;7：105-116.
Maeda I, Tajima S, Ariizumi Y, Doi M, Endo A, Naruki S, Hoshikawa M, Koizumi H, Kanemaki Y, Ueno T, Tsugawa K, Takagi M
Can synaptophysin be used as a marker of breast cancer diagnosed by core-needle biopsy in epithelial proliferative diseases of the breast?.
Pathology International , 2016;66(7)：369-375.
Tsuda T, Kyomori C, Mizukami T, Taniyama T, Izawa N, Horie Y, Hirakawa M, Ogura T, Nakajima TE, Tsugawa K, Boku N
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
mol clin Oncol. , 2016;4(4)：603-606.
② 症例報告
Oi R, Saji H, Marushima H, Maeda I, Takagi M, Nakamura H
Unusual presentation of pulmonary lymphoepithelioma-like carcinima.
Respirol Case Rep 4(5):e00177 doi: 10.1002/rcr2.177 2016 (Jul) , 2016;4(5)：e00177.
Kojima y, Tsuchiya K, Nishijima C, Suzuki , Tsugawa K
Fertility preservation for breast vanaer patients among reproductive age-a single institute experrience.
Global Breast Cancer Conference 2016, 2016.
Maeda I, Oana Y, Koizumi H, Tsugawa K, Takagi M
Double immunocytochemical staining of p63 and CK14 may be useful for the differential diagnosis of benign lesions and DCIS in fine needle aspiration.
ICC2016 The 19th International Congress of Cytology, 2016.
Oi Ryoko
Low-grade adenosquamous carcinoma coexisting with sclerosing adenosis of the breast:a case
report.
The 14th Asian Breast Diseases Association Meeting & Symposium, 2016.
Iwatani T
Japanese EQ-5D-3L health utility values;are these fit for purpose?.
ISOQOL 23rd Annual Conference, 2016.
Narui K, Ishikawa T, Shimizu D, Tanabe M, Sasaki T, Oba MS Saito, Morita S, Nawara S, KidaK, Mogaki M, Doi T, Tsugawa K, Ogata H, Ota T,Kosaka Y, Sengoku N, Kuranami M, Saito Y, Suzuki Y, Suto A, Arioka H, Chishima T, Ichikawa Y, Endo I, Tokuda Y.
A randomized phase Ⅱ nreoadjuvant study comparing docetaxel and cyclophosphamide(TC)with 5-fliorouracil,epirubicin,and cyclophosphamide followed by docetaxel(FEC-D)for hormone receptor-negative breast cancer.
2016 San Antonio Breast Cancer Symposium, 2016.
Villanueva C, Tsugawa K, Toyama T, Noh W, Jeong J, Cardoso F, Sriuranpong V, Srimuninnimit V, Ozguroglu M, Kendall S, Falkson C, Cianfrocca M, Manlius C, Lin JCJ CJ, Ringeisen F, Ridolfi A, Royce M.
Stomatitis in patients treated with first-line everolimus(EVE) plus letrozole(LET):Results from BOLERO-4 trial.
2016 San Antonio Breast Cancer Symposium, 2016.
